SCHEMBL21735535

SCHEMBL21735535

CCn1c(-c2ccccc2)cc2ccc(OC)cc21

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIK2 Q13002 2/20 0.79
GRIK1 P39086 1/20 0.79
MTNR1A P48039 2/20 0.63
MTNR1B P49286 2/20 0.63
NPSR1 Q6W5P4 3/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
MAPT P10636 1/20 0.56
RXFP1 Q9HBX9 1/20 0.56
ACSS2 Q9NR19 1/20 0.47
POLB P06746 1/20 0.45
TDP1 Q9NUW8 1/20 0.44
ALDH1A1 P00352 2/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
KDM4E B2RXH2 1/20 0.44
HPGD P15428 1/20 0.44
CYP1A2 P05177 1/20 0.43
CYP2A6 P11509 1/20 0.43
LYN P07948 1/20 0.43
SRC P12931 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7942901 0.91 GRIK2 (0.65) GRIK2GRIK1MTNR1AMTNR1BNPSR1
SCHEMBL8642549 0.88 GRIK2 (1.00) GRIK2GRIK1MTNR1AMTNR1BNPSR1
SCHEMBL21735538 0.85 MTNR1A (0.64) GRIK2GRIK1MTNR1AMTNR1BNPSR1
SCHEMBL21735533 0.85 GRIK1 (0.58) GRIK2GRIK1MTNR1AMTNR1BNPSR1
SCHEMBL26292352 0.85 GRIK2 (0.58) GRIK2GRIK1MTNR1AMTNR1BNPSR1
SCHEMBL11658854 0.84 GRIK2 (0.72) GRIK2GRIK1MTNR1AMTNR1BNPSR1
SCHEMBL23893652 0.80 GRIK2 (0.56) GRIK2GRIK1MTNR1AMTNR1BNPSR1
SCHEMBL21735692 0.80 MTNR1A (0.58) GRIK2GRIK1MTNR1AMTNR1BNPSR1
SCHEMBL11687963 0.80 KMT2A (0.62) GRIK2GRIK1MTNR1AMTNR1BNPSR1
SCHEMBL1171837 0.79 GRIK1 (0.65) GRIK2GRIK1MTNR1AMTNR1BALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11753387-B2 Compounds for optically active devices Johnson & Johnson Surgical Vision, Inc. (US) 2023-09-12 US disclosed
US-11753387-B2 Compounds for optically active devices Johnson & Johnson Surgical Vision, Inc. (US) 2023-09-12 US disclosed
EP-3889135-B1 COMPOUNDS FOR OPTICALLY ACTIVE DEVICES AMO Ireland (IE) 2023-08-02 EP disclosed
EP-3889135-A1 COMPOUNDS FOR OPTICALLY ACTIVE DEVICES Merck Patent GmbH (DE) 2021-10-06 EP disclosed
EP-3583092-B1 COMPOUNDS FOR OPTICALLY ACTIVE DEVICES MERCK PATENT GMBH (DE) 2021-05-26 EP disclosed
US-11014901-B2 Hydrophobic compounds for optically active devices MERCK PATENT GMBH (DE) 2021-05-25 US disclosed
US-11014900-B2 Hydrophilic compounds for optically active devices MERCK PATENT GMBH (DE) 2021-05-25 US disclosed
EP-3583098-B9 HYDROPHILIC COMPOUNDS FOR OPTICALLY ACTIVE DEVICES MERCK PATENT GMBH (DE) 2021-05-12 EP disclosed
EP-3583091-B1 HYDROPHOBIC COMPOUNDS FOR OPTICALLY ACTIVE DEVICES MERCK PATENT GMBH (DE) 2020-11-04 EP disclosed
EP-3583098-B1 HYDROPHILIC COMPOUNDS FOR OPTICALLY ACTIVE DEVICES MERCK PATENT GMBH (DE) 2020-10-28 EP disclosed
US-20200231559-A1 HYDROPHILIC COMPOUNDS FOR OPTICALLY ACTIVE DEVICES MERCK PATENT GMBH (DE) 2020-07-23 US disclosed
US-20200055833-A1 HYDROPHOBIC COMPOUNDS FOR OPTICALLY ACTIVE DEVICES MERCK PATENT GMBH (DE) 2020-02-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200055833-A1 HYDROPHOBIC COMPOUNDS FOR OPTICALLY ACTIVE DEVICES UACA, CRYZ, TRPA1 GRIK2 2281/4885GRIK1 1873/4885MTNR1A 3327/4885
US-11753387-B2 Compounds for optically active devices PDE6C, PDE6A, PDE6D GRIK2 1655/4885GRIK1 1140/4885MTNR1A 1345/4885
US-11014901-B2 Hydrophobic compounds for optically active devices UACA, CRYZ, TRPA1 GRIK2 2281/4885GRIK1 1873/4885MTNR1A 3327/4885
US-20200231559-A1 HYDROPHILIC COMPOUNDS FOR OPTICALLY ACTIVE DEVICES AQP1, AQP3, AQP4 GRIK2 1460/4885GRIK1 1093/4885MTNR1A 2807/4885
US-11014900-B2 Hydrophilic compounds for optically active devices AQP1, AQP3, AQP4 GRIK2 1460/4885GRIK1 1093/4885MTNR1A 2807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.